MicroRNAs as non-invasive biomarkers of heart transplant rejection

Abstract : Aim Rejection is one of the major causes of late cardiac allograft failure and at present can only be diagnosed by invasive endo-myocardial biopsies. We sought to determine whether microRNA profiling could serve as a non-invasive biomarker of cardiac allograft rejection. Methods We included 113 heart transplant recipients from four referral French institutions (test cohort, n ¼ 60, validation cohort, n ¼ 53). In the test cohort, we compared patients with acute biopsy-proven allograft rejection (n ¼ 30) to matched control patients without rejection (n ¼ 30), by assessing microRNAs expression in the heart allograft tissue and patients concomitant serum using RNA extraction and qPCR analysis. Fourteen miRNAs were selected on the basis of their implication in allograft rejection, endothelial activation, and inflammation and tissue specificity. Results We identified seven miRNAs that were differentially expressed between normal and rejecting heart allografts: miR-10a, miR-21, miR-31, miR-92a, miR-142-3p miR-155, and miR-451 (P , 0.0001 for all comparisons). Four out of seven miRNAs also showed differential serological expression (miR-10a, miR-31, miR-92a, and miR-155) with strong correlation with their tissular expression. The receiver-operating characteristic analysis showed that these four circulating miRNAs strongly discriminated patients with allograft rejection from patients without rejection: miR-10a (AUC ¼ 0.975), miR-31 (AUC ¼ 0.932), miR-92a (AUC ¼ 0.989), and miR-155 (AUC ¼ 0.998, P , 0.0001 for all comparisons). We confirmed in the external validation set that these four miRNAs highly discriminated patients with rejection from those without. The discrimination capability of the four miRNAs remained significant when stratified by rejection diagnosis (T-cell-mediated rejection or antibody-mediated rejection) and time post-transplant. Conclusion This study demonstrates that a differential expression of miRNA occurs in rejecting allograft patients, not only at the tissue level but also in the serum, suggesting their potential relevance as non-invasive biomarkers in heart transplant rejection.
Liste complète des métadonnées

Littérature citée [50 références]  Voir  Masquer  Télécharger

Contributeur : Venceslas Villier <>
Soumis le : jeudi 24 octobre 2019 - 09:41:33
Dernière modification le : samedi 26 octobre 2019 - 01:38:50


Accord explicite pour ce dépôt




Jean-Paul Duong van Huyen, Marion Tible, Arnaud Gay, Romain Guillemain, Olivier Aubert, et al.. MicroRNAs as non-invasive biomarkers of heart transplant rejection. European Heart Journal, Oxford University Press (OUP): Policy B, 2014, 35 (45), pp.3194-3202. ⟨10.1093/eurheartj/ehu346⟩. ⟨hal-02317970⟩



Consultations de la notice


Téléchargements de fichiers